Nuclear Newswire
  • Topics
    • Advanced Reactors
    • Advocacy
    • Conferences
    • Decontamination & Decommissioning
    • Education
    • Environmental Remediation
    • Fuel
    • Fusion
    • Industry
    • International
    • Isotopes & Radiation
    • Nonproliferation
    • Nuclear History
    • People
    • Policy
    • Power & Operations
    • Research & Applications
    • Security
    • Standards
    • Supply Chain
    • Transportation
    • Waste Management
    • Webinars
    • Workforce
  • Sources
    • Nuclear News
    • Radwaste Solutions
    • ANS News
    • ANS Nuclear Cafe
    • Sponsored Content
    • Press Releases
  • Sign Up
  • Buyers Guide
    • Access Online Buyers Guide
    • Manage/Create Company Listings
    • Advertise in Buyers Guides
  • Advertise
  • ANS
Headlines For You
  • Center for Used Fuel Research: Building confidence in storage and transport
    August 21, 2026, 3:02PM
  • Panelists talk domestic enrichment expansion at Global 2026
    August 21, 2026, 12:28PM
  • IAEA research project to develop hazard detection for edible insects
    August 21, 2026, 9:38AM
  • A message from Studsvik
    Transforming Nuclear Fuel Management with Intelligent Automation
  • New lab at ORNL speeds up U-233 cleanup, Ac-225 delivery
    August 21, 2026, 7:16AM
  • ANS names 2027 Congressional Fellows
    August 20, 2026, 3:31PM
  • Zeno RHU will aim to survive lunar night
    August 20, 2026, 12:00PM
  • A message from Gutor
    GUTOR 80: UPS, Battery Charger, & Inverter Solutions for Nuclear Applications, Built to ASME NQA-1
  • NRC opens, defines hearing opportunity for Orano’s Project Ike
    August 20, 2026, 9:27AM
  • For personalized headlines, please log in/create an account.
Latest Issue — Aug 2026
Latest Issue — Jan 2026

Newswire

Tag: fusion pharmaceuticals

Ageing nuclear assets don't have to mean higher maintenance costs. Discover how HVTS® cladding helps extend the life of PWR secondary system components, reduce outage duration, support ALARA principles, and protect against FAC, erosion-corrosion and other degradation mechanisms. Learn more.

Learn More

Isotopes & Radiation

BWXT to supply Ac-225 generation to Fusion Pharmaceuticals

November 20, 2023, 7:00AMNuclear News

BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.

LinkedInTwitterFacebookEmail
To continue reading, log in or create a free account!
Tags:
ac-225bwxt medicalfusion pharmaceuticalsmedical isotopesradioisotopes
Share:
Receive Nuclear News Daily
Join ANS Today
Donate Today
Trustees of Nuclear
Amentum
AMS
Clearpath
Constellation
Core Power
Dominion Engineering
Fissionaire
Global Laser Enrichment
Lightbridge
Mirion Technologies
Nuscale
Oklo
Orrick
Paragon
Radiant
Southern Nuclear
Studsvik
TerraPower
Urenco
X-Energy
American Nuclear Society

Advancing nuclear science and technology for the benefit of humanity

  • Advertising Opportunities
  • Navigating Nuclear
  • Contact Us
  • FacebookFacebook
  • TwitterTwitter
  • LinkedInLinkedIn
  • InstagramInstagram
  • YouTubeYouTube
  • PinterestPinterest
  • Nuclear NewswireNuclear Newswire
  • Email ListsEmail Lists

© Copyright 2026 American Nuclear Society

  • Privacy Policy
  • Terms of Use
  • Invoices
  • Media